Practical combination therapy of Amlodin and angiotensin II Receptor blocker(ARB); safety and efficacy in paTieNts with hypERtension Study (PARTNER Study).
Phase of Trial: Phase IV
Latest Information Update: 01 Jan 2015
At a glance
- Drugs Irbesartan (Primary) ; Amlodipine; Angiotensin receptor antagonists; Angiotensin type 2 receptor antagonists
- Indications Hypertension
- Focus Adverse reactions; Therapeutic Use
- Acronyms PARTNER
- 05 Jul 2011 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.
- 01 Jul 2011 New trial record